204 related articles for article (PubMed ID: 7863246)
1. Drug interactions of H2-receptor antagonists.
Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
[TBL] [Abstract][Full Text] [Related]
2. Short report: a comparative study of the interaction between antacid and H2-receptor antagonists.
Sullivan TJ; Reese JH; Jauregui L; Miller K; Levine L; Bachmann KA
Aliment Pharmacol Ther; 1994 Feb; 8(1):123-6. PubMed ID: 7910488
[TBL] [Abstract][Full Text] [Related]
3. Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients.
Bachmann K; Sullivan TJ; Mauro LS; Martin M; Jauregui L; Levine L
J Clin Pharmacol; 1992 May; 32(5):476-82. PubMed ID: 1587967
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
5. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
Desager JP; Harvengt C
J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
[TBL] [Abstract][Full Text] [Related]
7. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
Guram M; Howden CW; Holt S
Alcohol Clin Exp Res; 1991 Dec; 15(6):1084-5. PubMed ID: 1686371
[No Abstract] [Full Text] [Related]
9. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
[TBL] [Abstract][Full Text] [Related]
10. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
11. Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men.
Raufman JP; Notar-Francesco V; Raffaniello RD; Straus EW
Ann Intern Med; 1993 Apr; 118(7):488-94. PubMed ID: 8095127
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
13. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H; Naito T; Takeyama M
J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
15. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
17. [H2-receptor antagonists and alcohol: clinical significance].
Nemesánszky E; Csepregi A
Orv Hetil; 1996 Jun; 137(24):1309-13. PubMed ID: 8757090
[TBL] [Abstract][Full Text] [Related]
18. Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system.
van Zyl JM; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1993 Jun; 45(12):2389-97. PubMed ID: 8101078
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.
Kosh JW; Sowell JW; Chapman JM
Pharm Res; 1989 Aug; 6(8):709-13. PubMed ID: 2573049
[TBL] [Abstract][Full Text] [Related]
20. Effects of antacids on the clinical pharmacokinetics of drugs. An update.
Gugler R; Allgayer H
Clin Pharmacokinet; 1990 Mar; 18(3):210-9. PubMed ID: 1969784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
